Article info
PDFInflammatory bowel disease
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice
- Correspondence to Professor Stefan Fichtner-Feigl, Department of Surgery, University of Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg 93053, Germany; stefan.fichtner{at}klinik.uni-regensburg.de
Citation
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice
Publication history
- Revised June 17, 2011
- Accepted June 23, 2011
- First published September 23, 2011.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.